materials execs to board – BizWest

Ball Corp (BALL) plans to build a beverage can facility in Uttar Pradesh, India, expanding its presence in a key growth market. The investment aligns with its strategy to match capital expenditure with depreciation. In Q2 2026, BALL's Beverage Packaging EMEA segment, which includes India, reported $1.24B sales (up 10.6%) and $162M operating earnings (up 6.6%). Total sales rose 19.7% to $3.98B, beating estimates. Shares have gained 20% in the past year.

Ball Corp (BALL) reported Q2 FY2026 earnings Aug. 4. Net sales rose 19.7% YoY to $4.0B, driven by higher volumes and price/mix tied to aluminum prices. Comparable EPS increased 14.4% to $1.03. For FY2026, Ball expects >10% comparable diluted EPS growth and free cash flow >$900M. Analysts’ consensus is Moderate Buy; Citi raised its target to $75.

Ball (BALL) reported Q2 2026 results in an earnings call transcript. It said global volumes rose 4.3% year over year, comparable operating earnings increased 7.7%, and comparable diluted EPS grew 14.4%. For 2026, it reiterated 10%+ comparable diluted EPS growth, free cash flow above $900 million, and plans to return about $800 million to shareholders.

Ball Horticultural said it will expand its tropical category by acquiring Aris Horticulture’s Tradewinds Hibiscus genetics and parts of its tropical commercial business. Ball FloraPlant will take ownership of the full Tradewinds portfolio effective Aug. 3, while Ball Seed will handle commercial liner and prefinished/finished programs. Aris continues production and accepts orders through Aug. 17.

Ball Corporation reported Q2 2026 adjusted EPS of $1.03, above the $0.99 consensus, and revenue of $3.99B versus $3.68B expected. Global aluminum packaging shipments rose 4.3% year over year. Comparable operating earnings increased 7.7% to $433M. Ball kept its 2026 outlook, expecting >10% EPS growth and free cash flow over $900M.

Ball (NYSE: BALL) reported Q2 CY2026 revenue of $4.00B, up 19.7% year on year and above analysts’ $3.64B estimate, and non-GAAP EPS of $1.03, 4.3% above consensus. Operating margin fell to 8.7% from 10.3% a year earlier due to Millersburg start-up costs and tight North American capacity. Management expects capacity ramps by 2027.